Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus

Theriogenology

Volumn 73, Issue 8, 2010, Pages 1154-1163

  Rodning, Soren P ^a   Marley, M Shonda D ^a   Zhang, Yijing ^a   Eason, Andrew B ^a   Nunley, Callie L ^a   Walz, Paul H ^a   Riddell, Kay P ^a   Galik, Patricia K ^a   Brodersen, Bruce W ^b   Givens, M Daniel ^a  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Bovine viral diarrhea virus; Fetal protection; Persistently infected; Reproductive vaccines; Vaccination

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; BREEDING; CATTLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; VACCINATION; VERTICAL TRANSMISSION; VETERINARY ABORTION; VIROLOGY;

ABORTION, VETERINARY; ANIMALS; ANIMALS, NEWBORN; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; COMMERCE; DIARRHEA VIRUSES, BOVINE VIRAL; FEMALE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, ANIMAL; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

BOS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 77950021089     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2010.01.017     Document Type: Article

References (35)

1. Baker J.C. The clinical manifestations of bovine viral diarrhea infection. Vet Clin North Am Food Anim Pract 11 (1995) 425-445
2. Pellerin C., van den Hurk J., Lecomte J., and Tussen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203 (1994) 260-268
3. Ridpath J.F., Bolin S.R., and Dubovi E.J. Segregation of bovine viral diarrhea virus into genotypes. Virology 205 (1994) 66-74
4. Brock K.V., Grooms D.L., and Givens M.D. Reproductive disease and persistent infections. In: Goyal S.M., and Ridpath J.F. (Eds). Bovine viral diarrhea virus: diagnosis, management and control (2005), Blackwell Publishing Professional 145-156
5. Houe H., Baker J.C., Maes R.K., Wuryastuti H., Wasito R., Ruegg P.L., and Lloyd J.W. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody-positive cattle among herds with different infection and vaccination status. J Vet Diagn Invest 7 (1995) 321-326
6. Loneragan G.H., Thomson D.U., Montgomery D.L., Mason G.L., and Larson R.L. Prevalence, outcome, and health consequences associated with persistent infection with bovine viral diarrhea virus in feedlot cattle. J Am Vet Med Assoc 226 (2005) 595-601
7. Wittum T.E., Grotelueschen D.M., Brock K.V., Kvasnicka W.G., Floyd J.G., Kelling C.L., and Odde K.G. Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 49 (2001) 83-94
8. Brock K.V., Grooms D.L., Ridpath J., and Bolin S.R. Changes in levels of viremia in cattle persistently infected with bovine viral diarrhea virus. J Vet Diagn Invest 10 (1998) 22-26
9. Gunn G.J., Saatkamp H.W., Humphry R.W., and Stott A.W. Assessing economic and social pressure for the control of bovine viral diarrhoea virus. Prev Vet Med 72 (2005) 149-162 discussion 215-9
10. Moennig V., Houe H., and Lindberg A. BVD control in Europe: current status and perspectives. Anim Health Res Rev 6 (2005) 63-74
11. Valle P.S., Skjerve E., Martin S.W., Larssen R.B., Osteras O., and Nyberg O. Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis. Prev Vet Med 72 (2005) 189-207 discussion 15-9
12. Hult L., and Lindberg A. Experiences from BVDV control in Sweden. Prev Vet Med 72 (2005) 143-148 discussion 215-9
13. Ferrari G., Scicluna M.T., Bonvicini D., Gobbi C., Della Verita F., Valentini A., and Autorino G.L. Bovine virus diarrhoea (BVD) control programme in an area in the Rome province (Italy). Vet Microbiol 64 (1999) 237-245
14. Fulton R.W., and Burge L.J. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 19 (2000) 264-274
15. Cortese V.S., Grooms D.L., Ellis J., Bolin S.R., Ridpath J.F., and Brock K.V. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 59 (1998) 1409-1413
16. Zimmer G.M., Wentink G.H., Bruschke C., Westenbrink F.J., Brinkhof J., and de Goey I. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus. Vet Microbiol 89 (2002) 255-265
17. Patel J.R., Shilleto R.W., Williams J., and Alexander D.C. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Arch Virol 147 (2002) 2453-2463
18. Dean H.J., Hunsaker B.D., Bailey O.D., and Wasmoen T. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 64 (2003) 530-537
19. Fairbanks K.K., Rinehart C.L., Ohnesorge W.C., Loughin M.M., and Chase C.C. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. J Am Vet Med Assoc 225 (2004) 1898-1904
20. Ficken M.D., Ellsworth M.A., Tucker C.M., and Cortese V.S. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation. J Am Vet Med Assoc 228 (2006) 1559-1564
21. Ficken M.D., Ellsworth M.A., and Tucker C.M. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study. Vet Therapeutics 7 (2006) 283-294
22. Brock K.V., McCarty K., Chase C.C., and Harland R. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine. Vet Therapeutics 7 (2006) 27-34
23. Frey H.R., Eicken K., Grummer B., Kenklies S., Oguzoglu T.C., and Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J Vet Med B Infect Dis Vet Public Health 49 (2002) 489-493
24. Kovacs F., Magyar T., Rinehart C., Elbers K., Schlesinger K., and Ohnesorge W.C. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Vet Microbiol 96 (2003) 117-131
25. Brownlie J., Clarke M.C., Hooper L.B., and Bell G.D. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec 137 (1995) 58-62
26. Fulton R.W., Johnson B.J., Briggs R.E., Ridpath J.F., Saliki J.T., Confer A.W., Burge L.J., Step D.L., Walker D.A., and Payton M.E. Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves. Can J Vet Res 70 (2006) 121-127
27. Grooms D.L., Bolin S.R., Coe P.H., Borges R.J., and Coutu C.E. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle. Am J Vet Res 68 (2007) 1417-1422
28. Walz P.H., Givens M.D., Cochran A., and Navarre C.B. Effect of dexamethasone administration on bulls with a localized testicular infection with bovine viral diarrhea virus. Can J Vet Res 72 (2008) 56-62
29. Reed L.J., and Muench H. A simple method of estimating fifty percent end points. Am J Hygiene 27 (1938) 493-497
30. Afshar A., Dulac G.C., Dubuc C., and Howard T.H. Comparative evaluation of the fluorescent antibody test and microtiter immunoperoxidase assay for detection of bovine viral diarrhea virus from bull semen. Can J Vet Res 55 (1991) 91-93
31. Givens M.D., Heath A.M., Brock K.V., Brodersen B.W., Carson R.L., and Stringfellow D.A. Detection of bovine viral diarrhea virus in semen obtained after inoculation of seronegative postpubertal bulls. Am J Vet Res 64 (2003) 428-434
32. Givens M.D., Galik P.K., Riddell K.P., Brock K.V., and Stringfellow D.A. Replication and persistence of different strains of bovine viral diarrhea virus in an in vitro embryo production system. Theriogenology 54 (2000) 1093-1107
33. Ellsworth M.A., Fairbanks K.K., Behan S., Jackson J.A., Goodyear M., Oien N.L., Meinert T.R., and Leyh R.D. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams. Vet Ther 7 (2006) 295-304
34. Fulton R.W., Ridpath J.F., Confer A.W., Saliki J.T., Burge L.J., and Payton M.E. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 31 (2003) 89-95
35. Fulton R.W., Ridpath J.F., Ore S., Confer A.W., Saliki J.T., Burge L.J., and Payton M.E. Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV1a, 1b, and 2a subgenotypes. Vet Microbiol 111 (2005) 35-40